Riskpilot← Back to searchSign inGet full accessVEITVETKLINIKKEN AS
ASActiveOrg 987444908Veitvetveien 8, 0596 OsloGeneral medical practice activities · NACE 8621Est. 20047 employeeswww.linderudklinikken.no
Revenue 2024
NOK 3,2M
-7% vs 2023
EBITDA margin
-2.5%
-693% vs 2023
Equity ratio
21.8%
Financial strength
Net profit 2024
NOK -109K
-337% vs 2023
| Revenue | NOK 3,2M | -7% |
| EBITDA | NOK -82K | -693% |
| Net profit | NOK -109K | -337% |
| Total assets | NOK 626K | -8% |
| Equity | NOK 137K | -44% |
| Employees | 7 | — |
Legal name
VEITVETKLINIKKEN AS
Org number
987444908
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
15. november 2004
Share capital
NOK 100 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Legesenter. Selskapet kan gjennom aksjetegning gjøre seg interessert i andre foretagender.
Address
Veitvetveien 8, 0596 Oslo
Phone
+4722803960
Email
resepsjonen@linderudklinikken.nhn.no
Website
www.linderudklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 758 | 3 342 | 2 772 | 3 451 | 3 221 |
| Staff expenses | −945 | −982 | −1 015 | −986 | −1 129 |
| EBITDA | 80 | 7 | 1 | 14 | −81 |
| Depreciation & amort. | −6 | −6 | −6 | −6 | −0 |
| EBIT | 74 | 1 | −5 | 8 | −81 |
| Net financials | −0 | −0 | −1 | −14 | −27 |
| Profit before tax | 74 | 1 | −6 | −6 | −109 |
| Tax | 17 | 0 | 1 | 19 | −0 |
| Net profit | 57 | 1 | −6 | −25 | −109 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 991 | 1 069 | 605 | 680 | 626 |
| Equity | 276 | 276 | 270 | 245 | 137 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 715 | 793 | 335 | 437 | 491 |
| Total debt | 715 | 793 | 335 | 437 | 491 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20202024
Equity ratio
21.8%
This company
38.2%
Market median
-43% vs market
20202024
Return on equity
-79.5%
This company
18.4%
Market median
-532% vs market
20202024
Net profit margin
-3.4%
This company
8.1%
Market median
-142% vs market
20202024
Asset turnover
5.15×
This company
1.12×
Market median
+360% vs market
20202024
Debt / equity
3.58×
This company
0.62×
Market median
-477% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NB Chief Executive Officer | Chief Executive Officer | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2013 | |
| Board of Directors | 2026 | |
| Board of Directors | 2013 | |
| Board of Directors | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VEITVETKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nazia Batool | Chief Executive Officer | 0 companies |
| Shah Murad | Chairman | 0 companies |
| Ambrin Mirza | Board of Directors | 0 companies |
| Zahid Mukhtar | Board of Directors | 0 companies |
| Anjum Nawaz | Board of Directors | 0 companies |